Viewing Study NCT02609503


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-04-06 @ 12:50 PM
Study NCT ID: NCT02609503
Status: COMPLETED
Last Update Posted: 2024-11-05
First Post: 2015-11-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization: